Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas, a cohort study

CONCLUSIONS: In well selected microprolactinoma patients, pituitary surgery performed by an expert neurosurgical team is a valid first-line alternative treatment to dopamine agonists.PMID:34605772 | DOI:10.1530/EJE-21-0293

Source: European Journal of Endocrinology - October 4, 2021 Category: Endocrinology Authors: Bertrand Baussart Chiara Villa Anne Jouinot Marie-Laure Raffin-Sanson Luc Foubert Laure Cazabat Michele Bernier Fid éline Bonnet Anthony Dohan Jerome Bertherat Guillaume Assie Stephan Gaillard Source Type: research